About Amsterdam UMC

Organization

  • Transgender women do not have an increased risk of heart attack and stroke
    Transgender women do not have an increased risk of heart attack and stroke Contrary to previous research, transgender women who use the hormone oestradiol for their transition do not have an increased risk of heart attack and stroke compared to men in the general Dutch population. This is shown by a large-scale study from Amsterdam UMC, with data from more than 4,000 transgender individuals, published today in the European Heart Journal. The researchers suspect that the hormone treatment transgender women receive has a protective effect on the heart and blood vessels.
  • Hunting for the Crohn's Holy Grail
    Hunting for the Crohn's Holy Grail Crohn's disease turns the lives of young patients upside down. Work, relationships, children: often all three need to put on hold. Jean-Frédéric Colombel's mission is to give these patients their lives back. Through medication, operations, prevention, but preferably by finding the ultimate cause and cure. He will give an update about his search for this holy grail during the Anatomy Lesson, on 20 November in the Concertgebouw.
  • Addition of Progesterone Leads to Increased Breast Growth for Transgender Women
    Addition of Progesterone Leads to Increased Breast Growth for Transgender Women The addition of the hormone progesterone to gender-affirming hormone therapy leads to increased breast growth for transgender people following feminising hormone therapy. This is demonstrated by an Amsterdam UMC-led trial among 90 participants and these results are presented today at the European Professional Association for Transgender Health (EPATH) annual congress in Hamburg.

Amsterdam UMC is hiring

We are always on the lookout for talented and passionate people to join our growing team. You will have the opportunity to develop any aspects you are interested in.

See all our vacancies (in Dutch):

Amsterdam UMC is hiring